114 related articles for article (PubMed ID: 11716232)
41. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
42. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
Díez JJ; Iglesias P
J Endocrinol Invest; 2002 Oct; 25(9):773-8. PubMed ID: 12398235
[TBL] [Abstract][Full Text] [Related]
43. Reoperation for recurrent or persistent medullary thyroid cancer.
Moley JF; Wells SA; Dilley WG; Tisell LE
Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
[TBL] [Abstract][Full Text] [Related]
44. [Familial medullary carcinoma of the thyroid. The usefulness of ultrasonography and Doppler color].
Fernández García P; Cervera Deval J; Marco Doménech SF; Laguna Sastre M
Rev Clin Esp; 1998 Nov; 198(11):745-8. PubMed ID: 9883048
[TBL] [Abstract][Full Text] [Related]
45. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
Pichon MF; Coquin G; Fauveau C; Rey A
Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121
[TBL] [Abstract][Full Text] [Related]
46. [Early diagnosis of sporadic medullary cancers of the thyroid: value of systematic assay of calcitonin].
Henry JF; Denizot A; Puccini M; Niccoli P; Conte-Devolx B; de Micco C
Presse Med; 1996 Nov; 25(33):1583-8. PubMed ID: 8952672
[TBL] [Abstract][Full Text] [Related]
47. [Neuroendocrine carcinoma of the larynx with secretion of calcitonin: primary tumor or metastasis of the medullary thyroid carcinoma?].
Vildé F; Arkwright S; Paoli C; Périchon I; Le Charpentier Y; Le Bodic MF
Ann Pathol; 1996; 16(2):104-7. PubMed ID: 8767676
[TBL] [Abstract][Full Text] [Related]
48. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
[TBL] [Abstract][Full Text] [Related]
49. Early diagnosis of medullary thyroid carcinoma in a 13 years old girl.
Misíková Z; Kostálová L; Podaná S; Knotek J; Caradská A
Neoplasma; 1995; 42(1):43-5. PubMed ID: 7617075
[TBL] [Abstract][Full Text] [Related]
50. [Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
Gómez-Camarero P; Ortiz-de Tena A; Borrego-Dorado I; Vázquez-Albertino RJ; Navarro-González E; Ruiz-Franco-Baux JV; Cuenca-Cuenca JI
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):261-6. PubMed ID: 23067528
[TBL] [Abstract][Full Text] [Related]
51. The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer.
Fersht N; Vini L; A'Hern R; Harmer C
Thyroid; 2001 Dec; 11(12):1161-8. PubMed ID: 12186504
[TBL] [Abstract][Full Text] [Related]
52. A decrease of calcitonin serum concentrations less than 50 percent 30 minutes after thyroid surgery suggests incomplete C-cell tumor tissue removal.
Faggiano A; Milone F; Ramundo V; Chiofalo MG; Ventre I; Giannattasio R; Severino R; Lombardi G; Colao A; Pezzullo L
J Clin Endocrinol Metab; 2010 Sep; 95(9):E32-6. PubMed ID: 20534767
[TBL] [Abstract][Full Text] [Related]
53. Medullary thyroid carcinoma: a rare presentation as a hypervascular tumour.
Li WY; Tomlinson MA; Bryson JM; Hopkins NF
J Laryngol Otol; 2002 Aug; 116(8):647-9. PubMed ID: 12389699
[TBL] [Abstract][Full Text] [Related]
54. Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.
Elisei R; Lorusso L; Romei C; Bottici V; Mazzeo S; Giani C; Fiore E; Torregrossa L; Insilla AC; Basolo F; Guerini A; Menghi A; Poletti A; Cugudda L; Vitti P
J Clin Endocrinol Metab; 2013 Sep; 98(9):3550-4. PubMed ID: 23861463
[TBL] [Abstract][Full Text] [Related]
55. [Multimodal imaging in medullary thyroid carcinomas].
Müssig K; Bares R; Horger M
Rofo; 2010 Nov; 182(11):925-8. PubMed ID: 21031322
[No Abstract] [Full Text] [Related]
56. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
Ide A; Ashizawa K; Ishikawa N; Ishii R; Ando T; Abe Y; Sera N; Usa T; Tominaga T; Ejima E; Nakashima M; Ito K; Ito K; Eguchi K
Thyroid; 2001 Nov; 11(11):1055-61. PubMed ID: 11762716
[TBL] [Abstract][Full Text] [Related]
57. Medullary Thyroid Carcinoma Associated with Germline RET
Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ
Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361
[TBL] [Abstract][Full Text] [Related]
58. Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer.
Kim HK; Bae WK; Choi YD; Shim HJ; Yoon JH; Kang HC
Thyroid; 2014 Mar; 24(3):599-603. PubMed ID: 23985043
[TBL] [Abstract][Full Text] [Related]
59. Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma.
Abdelmoumene N; Schlumberger M; Gardet P; Roche A; Travagli JP; Francese C; Parmentier C
Br J Cancer; 1994 Jun; 69(6):1141-4. PubMed ID: 8198983
[TBL] [Abstract][Full Text] [Related]
60. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
